• Markets
    • icon
  • Companies
MDR · ASX

MedAdvisor Limited (ASX:MDR)

AU$0.21

 0.0 (0.0%)
ASX:Live
08/12/2023 03:03:22 PM
Recent Earnings downgrade HALO Ords GROWTH AUS Fakey Shakey - Short All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

MDR Overview

MDR Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About MDR

Website

MedAdvisor Limited

Telephone

61.3.9095.3036

Address

Level 2 971 Burke Road Camberwell, Victoria (VIC) 3124

Description

MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. It operates through the following segments: MedAdvisor and Corporate. The MedAdvisor segment includes medication management and adherence platform. The Corporate segment comprises of the company's function associated with being an ASX listed company. MedAdvisor was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.

MDR Price Chart

Key Stats

Market Cap

AU$114.86M

PE

55.40

EV/EBITDA

15.9

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.16 - 0.31

Trade Value (12mth)

AU$17,854.00

1 week

-2.33%

1 month

23.53%

YTD

-19.23%

1 year

5%

All time high

1.725

Key Fundamentals

EPS 3 yr Growth

-48.900%

EBITDA Margin

-2.40%

Operating Cashflow

-$1m

Free Cash Flow Return

-2.80%

ROIC

-21.90%

Interest Coverage

-1.10

Quick Ratio

0.80

Other Data

Shares on Issue (Fully Dilluted)

536m

HALO Sector

Technology

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.01

MDR Announcements

Latest Announcements

Date Announcements

31 July 23

4C Q4 FY23 Medadvisor Quarterly Update - 31 July 2023

×

4C Q4 FY23 Medadvisor Quarterly Update - 31 July 2023

31 August 22

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

31 August 18

MedAdvisor FY18 Annual Report & Appendix 4E

×

MedAdvisor FY18 Annual Report & Appendix 4E

30 September 14

Exalt Resources Limited - Annual Report to shareholders (ERD-AU)

×

Exalt Resources Limited - Annual Report to shareholders (ERD-AU)

30 September 13

Exalt Resources Limited - Annual Report to shareholders (ERD-AU)

×

Exalt Resources Limited - Annual Report to shareholders (ERD-AU)

30 October 23

Q1 FY24 MDR Quarterly Update

×

Q1 FY24 MDR Quarterly Update

30 November 22

AGM Presentation

×

AGM Presentation

30 November 22

AGM Chair and CEO Addresses

×

AGM Chair and CEO Addresses

30 November 22

Results of AGM

×

Results of AGM

30 November 22

Constitution

×

Constitution

30 November 22

Notification of cessation of securities - MDR

×

Notification of cessation of securities - MDR

30 November 22

Change of Director's Interest Notice - Read

×

Change of Director's Interest Notice - Read

30 November 22

Final Director's Interest Notice

×

Final Director's Interest Notice

30 November 22

Notification regarding unquoted securities - MDR

×

Notification regarding unquoted securities - MDR

30 November 22

Change of Director's Interest Notice - Ratliff

×

Change of Director's Interest Notice - Ratliff

30 November 22

Change of Director's Interest Notice - Jenkinson

×

Change of Director's Interest Notice - Jenkinson

30 November 22

Change of Director's Interest Notice - Hook

×

Change of Director's Interest Notice - Hook

30 November 22

Change of Director's Interest Notice - Hutchinson

×

Change of Director's Interest Notice - Hutchinson

30 November 22

Change of Director's Interest Notice - Merrow

×

Change of Director's Interest Notice - Merrow

30 November 22

Change of Director's Interest Notice - Xenos

×

Change of Director's Interest Notice - Xenos

30 November 12

Exalt Resources Limited - AGM 2012 Presentation (ERD-AU)

×

Exalt Resources Limited - AGM 2012 Presentation (ERD-AU)

30 November 12

Exalt Resources Limited - AGM / UK Roadshow Investor Presentation (ERD-AU)

×

Exalt Resources Limited - AGM / UK Roadshow Investor Presentation (ERD-AU)

30 March 23

Appointment of Company Secretary

×

Appointment of Company Secretary

30 August 23

MedAdvisor Appendix 4G

×

MedAdvisor Appendix 4G

30 August 23

MedAdvisor Corporate Governance Statement

×

MedAdvisor Corporate Governance Statement

30 August 23

MDR Appendix 4E and FY23 Annual Report

×

MDR Appendix 4E and FY23 Annual Report

30 August 23

MDR delivered strong financial results in FY23

×

MDR delivered strong financial results in FY23

MDR Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.04 -0.05 -0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.04 -0.05 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -8.4 -4.1 54.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A 55.4 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A 15.9 Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.02 -0.03 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.04 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 42.7 -61.9 74.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock -13.6 -0.9 -1.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.13 0.09 0.11 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.02 -0.06 -0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock -135.4 -254.3 28.9 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 317 378 545 Lock Lock Lock
Basic m Lock Lock Lock Lock 317 378 545 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 39 68 98 Lock Lock Lock
     Growth % Lock Lock Lock Lock 303.8 74.7 44.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 12 14 20 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -6 -2 13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -66.8 69.6 783.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -15.6 -2.7 12.8 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 116 103 87 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -15 -11 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -42.2 25.2 79.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -38.9 -16.7 -2.4 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 3 5 5 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -18 -16 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -64.5 11.6 52.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -47.2 -23.9 -7.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -19 -18 -11 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -4 0 1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -14 -17 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock -45.5 -24.4 34.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -36.0 -25.6 -11.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -13 0 -1 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -43 0 -3 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 51 2 12 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -13 -1 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -47.3 95.8 -197.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.3 -0.0 -0.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 7 8 14 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 81 78 96 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 8 8 12 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 2 6 -1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 32 44 47 Lock Lock Lock
Equity $m Lock Lock Lock Lock 48 35 48 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 56 43 61 Lock Lock Lock
     Growth % Lock Lock Lock Lock 214.5 -24.2 43.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -17.2 -22.1 -11.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -28.8 -50.2 -23.3 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -47.9 -30.6 -14.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -37.8 -35.2 -21.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -34.0 -0.5 -2.8 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -35.8 -7.3 -1.1 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -0.1 -0.5 0.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 4.1 16.9 -2.3 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.9 0.5 0.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.9 0.5 0.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 33.5 41.0 50.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -53.9 -0.7 -4.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 5.4 6.3 9.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 9.8 8.9 4.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.9 1.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.9 1.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -47.9 -26.2 -10.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -22.9 -22.6 -11.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -17.2 -22.1 -11.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.7 2.3 2.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -28.8 -50.2 -23.3 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -28.8 -50.2 -23.3 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 67.3 58.0 38.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 67.3 58.0 38.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 18.3 25.7 21.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 49.0 32.3 17.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.01%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

MDR Shortsell

Frequently Asked Questions

The current share price of MedAdvisor Limited (MDR:ASX) is AU$0.21.
The 52-week high share price for MedAdvisor Limited (MDR:ASX) is AU$0.31.
The 52-week low share price for MedAdvisor Limited (MDR:ASX)? is AU$0.16.
The current TTM dividend payout for MedAdvisor Limited (MDR:ASX) is 0.00.
MedAdvisor Limited (MDR:ASX) does not pay a dividend.
MedAdvisor Limited (MDR:ASX) has a franking level of 0%.
MedAdvisor Limited (MDR:ASX) is classified in the Technology.
The current P/E ratio for MedAdvisor Limited (MDR:ASX) is 55.40.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.